Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes

Magnetic drug targeting (MDT) improves the integrity of healthy tissues and cells during treatment with cytotoxic drugs. An anticancer drug is bound to superparamagnetic iron oxide nanoparticles (SPION), injected into the vascular supply of the tumor and directed into the tumor by means of an extern...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Janko, Christina, Dürr, Stephan, Munoz, Luis E., Lyer, Stefan, Chaurio, Ricardo, Tietze, Rainer, von Löhneysen, Sarah, Schorn, Christine, Herrmann, Martin, Alexiou, Christoph
Format: Artigo
Jezik:Inglês
Izdano: Molecular Diversity Preservation International (MDPI) 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3645689/
https://ncbi.nlm.nih.gov/pubmed/23549268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms14047341
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items